- Home
- » Tags
- » Faralimomab
Top View
- International Nonproprietary Names (INN) for Biological and Biotechnological Substances
- International Nonproprietary Names for Pharmaceutical Substances
- Wo 2010/095940 A2
- Customs Tariff - Schedule Xxi - 1
- Fig. 2 O W O 2012/149282 A2 1Inn Iiiiiii 1Mil I Mil Il I 1Ill I Mil I Il I I Mill Mi I I
- The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
- The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances 2009
- Gm, Ke, Lr, Ls, Mw, Mz, Na, Rw, Sd, Sl, St, Sz, Tz, Ug, Zm, Zw
- Pharmaceutical Appendix to the Tariff Schedule 2
- Esophagitis: Drugs Picture of Iron Pill Material in Biopsy TT’S Kodachrome 1St Page Folder Iron Medication Injury Medications/Drugs
- Immunomodulatory Treatment for the Intractable Paediatric Epilepsies Luis E
- The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
- (INN) for Biological and Biotechnological Substances
- Thalidomide - Wikipedia, the Free Encyclopedia
- Assessment of the Evolution of Cancer Treatment Therapies
- WO 2015/036956 Al 19 March 2015 (19.03.2015) P O P C T
- Rna Containing Composition for Treatment of Tumor Diseases
- International Nonproprietary Names (INN) for Biological and Biotechnological Substances
- Dexamethasone to Reduce Stem Cell Accumulation in the Spleen
- Who Drug Information
- (12) Patent Application Publication (10) Pub. No.: US 2015/0374790 A1 Liu Et Al